Exenatide improves metabolic disorders in serum of HFD-challenged mice After the 8 week exenatide treatment, we found a dramatic reduction in fasting blood glucose (FBG) and lipid metabolites, including TG, glycerol and NEFA, in the serum of the HFD group with exenatide treatment (Table 1)
Safety Outcomes The incidences of any on-treatment AEs, gastrointestinal AEs, serious AEs and AEs leading to trial product discontinuation by treatment and background medication subgroup are shown in Table 3
The glucosinolate glucoraphanin of broccoli sprouts interacts with myrosinase to produce the phytochemical sulforaphane (SFN) (Figure 6)
Dr Kadam said the study was relevant to Australia as more and more people were now on GLP1-RAs drugs
One of the most important PD-associated genes is PINK1 (PTEN-induced putative kinase 1), encoding PTEN-induced serine/threonine kinase 1, and PRKN, encoding an E3 ubiquitin ligase Parkin
Contraindications must be respected regardless of potential benefits
